Literature DB >> 21969051

Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.

Curtis McKnight, Hossam Guirgis, Nick Votolato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21969051     DOI： 10.1176/appi.ajp.2011.11020202

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

2.  Re-titration rates after clozapine-induced neutropenia or agranulocytosis: A case report and literature review.

Authors:  Mina Boazak; Benjamin Kahn; Lindsay Cox; James Ragazino; David R Goldsmith; Robert O Cotes
Journal:  Clin Schizophr Relat Psychoses       Date:  2018-06-26

Review 3.  When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.

Authors:  Peter Manu; Deepak Sarpal; Owen Muir; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2011-11-22       Impact factor: 4.939

4.  Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.

Authors:  Samar S M Elsheikh; Daniel J Müller; Jennie G Pouget
Journal:  Methods Mol Biol       Date:  2022

5.  Clozapine reinitiation following a "red result" secondary to chemotherapy.

Authors:  Tariq Munshi; Mir Mazhar; Tariq Hassan
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-27       Impact factor: 2.570

6.  Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.

Authors:  Aakanksha Singh; Sandeep Grover; Pankaj Malhotra; Subhash C Varma
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.